Webinar: From Mutation to Treatment: Understanding the Impact of IDH Inhibitors
In this informative webinar, we’ll explore the role of IDH inhibitors in brain tumor care, including what they are and how they impact diagnosis and treatment decisions. Attendees will learn about the latest advancements in IDH-targeted therapies, including the newly FDA-approved treatment, vorasidenib. Whether you’re a patient, caregiver, or advocate, this session will provide valuable […]